Aigen Investment Management LP Acquires New Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Aigen Investment Management LP bought a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,873 shares of the company’s stock, valued at approximately $237,000.

Several other large investors have also recently modified their holdings of the business. GAMMA Investing LLC purchased a new position in Prestige Consumer Healthcare in the 4th quarter valued at approximately $25,000. Pacer Advisors Inc. raised its stake in shares of Prestige Consumer Healthcare by 85.7% during the 4th quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock valued at $27,000 after purchasing an additional 204 shares during the period. Provence Wealth Management Group purchased a new stake in Prestige Consumer Healthcare during the 3rd quarter worth about $26,000. Principal Securities Inc. bought a new position in Prestige Consumer Healthcare in the 4th quarter worth about $29,000. Finally, ORG Partners LLC purchased a new position in Prestige Consumer Healthcare during the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.2 %

NYSE:PBH opened at $63.97 on Monday. The firm has a market capitalization of $3.19 billion, a P/E ratio of 15.34, a P/E/G ratio of 1.81 and a beta of 0.53. The company has a quick ratio of 2.02, a current ratio of 3.20 and a debt-to-equity ratio of 0.68. The company has a fifty day moving average of $69.68 and a 200 day moving average of $65.49. Prestige Consumer Healthcare Inc. has a 52 week low of $55.96 and a 52 week high of $75.31.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last released its quarterly earnings data on Tuesday, May 14th. The company reported $1.02 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.12). Prestige Consumer Healthcare had a return on equity of 13.48% and a net margin of 18.60%. The business had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $287.42 million. During the same quarter last year, the business posted $1.07 EPS. The company’s quarterly revenue was down 3.1% compared to the same quarter last year. On average, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.41 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on PBH shares. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. Canaccord Genuity Group restated a “buy” rating and set a $80.00 price target on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. StockNews.com lowered Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, May 21st. Finally, DA Davidson reiterated a “neutral” rating and set a $65.00 price target on shares of Prestige Consumer Healthcare in a research report on Thursday, May 16th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $91.25.

View Our Latest Research Report on Prestige Consumer Healthcare

About Prestige Consumer Healthcare

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Articles

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.